The role of endogenous H2S in cardiovascular physiology

Current Pharmaceutical Biotechnology

Volumn 12, Issue 9, 2011, Pages 1385-1393

  Skovgaard, Nini ^a   Gouliaev, Anja ^a   Aalling, Mathilde ^a   Simonsen, Ulf ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Oxygen sensing; Pathophysiology; Pulmonary circulation; Systemic circulation; Vasocontriction; Vasodilatation

Indexed keywords

3 MERCAPTOPYRUVATE SULFURESTERASE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CALCIUM; CYCLIC AMP; CYSTATHIONINE GAMMA LYASE; CYSTEINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; ESTERASE; HYDROGEN SULFIDE; NITRIC OXIDE; NITROSO DERIVATIVE; THIOL DERIVATIVE; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED POTASSIUM CHANNEL;

ARTICLE; CALCIUM CELL LEVEL; CARDIOVASCULAR SYSTEM; ENDOTHELIUM CELL; HUMAN; HYPERPOLARIZATION; HYPERTENSION; ISCHEMIC HEART DISEASE; NONHUMAN; OXYGEN SENSING; PULMONARY HYPERTENSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SYSTEMIC CIRCULATION; VASOCONSTRICTION; VASODILATATION; ANIMAL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; LUNG CIRCULATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; HUMANS; HYDROGEN SULFIDE; PULMONARY CIRCULATION;

EID: 80052221610     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920111798280956     Document Type: Article

References (96)

1. Szabó, C. Hydrogen sulphide and its therapeutic potential. Nat. Rev., 2007, 6, 917-935.
2. Stipanuk, M. H.; Beck, P. W. Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat. Biochem. J., 1982, 206, 267-277.
3. Shibuya, N.; Mikami, Y.; Kimura, Y.; Nagahara, N.; Kimura, H. Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. J. Biochem., 2009, 146, 623-626.
4. 2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine-gamma-lyase. Science, 2008, 322, 587-590.
5. 2S as a novel endogenous gaseous K-ATP channel opener. EMBO J., 2001, 20, 6008-6016.
6. Goubern, M.; Andriamihaja, M.; Nübel, T.; Blachier, F.; Bouillaud, F. Sulfide, the first inorganic substrate for human cells. FASEB J., 2007, 21, 1699-1706.
7. Hildebrandt, T. M.; Grieshaber, M. K. Three enzymatic activities catalyze the oxidation of sulfide to thiosulfate in mammalian and invertebrate mitochondria. FEBS J., 2008, 275, 3352-3361.
8. Levitt, M.D.; Furne, J.; Springfield, J.; Suarez, F.; DeMaster, E. Detoxification of hydrogen sulfide and methanethiol in the cecal mucosa. J. Clin. Invest., 1999, 104, 1107-1114.
9. Volkel, S.; Berenbrink, M. Sulphaemoglobin formation in fish: a comparison between the haemoglobin of the sulphide-sensitive rainbow trout (Oncorhynchus mykiss) and of the sulphide-tolerant common carp (Cyprinus carpio). J. Exp. Biol., 2000, 203, 1047-1058.
10. Dombkowski, R. A.; Russell, M. J.; Olson, K. R. Hydrogen sulfide as an endogenous regulator of vascular smooth muscle tone in trout. Am. J. Physiol., 2004, 286, R678-R685.
11. 2S and HS- donor NaHS releases nitric oxide from nitrosothiols, metal nitrosyl complex, brain homogenate and murine L1210 leukaemia cells. Pflugers Arch. - Eur. J. Physiol., 2008, 457, 271-279.
12. 2S/sulfide concentration in vertebrate blood and its potential significance in ischemic preconditioning and vascular signaling. Am. J. Physiol., 2008, 294, R1930-1937.
13. Petersen, L.C. The effect of inhibitors on the oxygen kinetics of cytochrome coxidase. Biochim. Biophys. Acta., 1977, 460, 299-307.
14. Ali, M.Y.; Ping, C. Y.; Mok, Y. P.; Ling, L.; Whiteman, M.; Bhatia, M.; Moore, P. K. Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide? Br. J. Pharmacol., 2006, 149, 625-634.
15. Li, L.; Whiteman, M.; Guan, Y.Y.; Neo, K. L.; Cheng, Y.; Lee, S. W.; Zhao, Y.; Baskar, R.; Tan, C. H.; Moore, P. K. Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide. Circulation, 2008, 117, 2351-2360.
16. Dawe, G. S.; Han, S. P.; Bian, J. S.; Moore, P. K. Hydrogen sulphide in the hypothalamus causes an ATP-sensitive K+ channeldependent decrease in blood pressure in freely moving rats. Neuroscience, 2008, 152, 169-177.
17. Ufnal, M.; Sikora, M.; Dudek, M. Exogenous hydrogen sulfide produces hemodynamic effects by triggering central neuroregulator mechanisms. Acta. Neurobiol. Exp., 2008, 68, 382-388.
18. Cheng, Y.; Ndisang, J. F.; Tang, G.; Cao, K; Wang, R. Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats. Am. J. Physiol., 2004, 287, H2316-H2323.
19. 2S regulates perfusion pressure in both the isolated and perfused normal rat liver and cirrhosis. Hepatology, 2005, 42, 539-548.
20. 2S contributes to the hepatic arterial buffer response and mediates vasorelaxation of the hepatic artery via activation of KATP channels. Am. J. Physiol., 2008, 295, G1263-G1273.
21. Srilatha, B.; Adaikan, P.G.; Li, L.; Moore, P. K. Hydrogen sulfide: a novel endogenous gasotransmitter facilitates erectile function. J. Sex. Med., 2007, 4, 1304-1311.
22. di Villa Bianca, R.E.; Sorrentino, R.; Maffia, P.; Mirone, V.; Imbimbo, C.; Fusco, F.; De Palma, R.; Ignarro, L. J.: Cirino, G. Hydrogen sulfide as a mediator of human corpus cavernosum smooth-muscle relaxation. Proc. Natl. Acad. Sci., 2009, 106, 4513-4518.
23. Cheang, W. S.; Wong, W. T.; Shen, B.; Lau, C. W.; Tian, X.Y.; Tsang, S. Y.; Yao, X.; Chen, Z. Y.; Huang, Y. 4-Aminopyridinesensitive K+ channels contributes to NaHS-induced membrane hyperpolarization and relaxation in the rat coronary artery. Vascul. Pharmacol., 2010, DOI: 10.1016/j.vph.2010.04.004.
24. Hosoki, R.; Matsuki, N.; Kimura, H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem. Biophys. Res. Commun., 1997, 237, 527-531.
25. Dombkowski, R. A.; Russell, M. J.; Schulman, A. A.; Doellman, M. M.; Olson, K. R. Vertebrate phylogeny of hydrogen sulfide vasoactivity. Am. J. Physiol., 2005, 288, R243-R252.
26. Kubo, S.; Doe, I.; Kurokawa, Y.; Nishikawa, H.; Kawabata, A. Direct inhibition of endothelial nitric oxide synthase by hydrogen sulfide: contribution to dual modulation of vascular tension. Toxicology, 2007, 232, 138-146.
27. Webb, G. D.; Lim, L. H.; Oh, V. M. S.; Yeo, S. B.; Cheong, Y. P.; Ali, M.Y.; El Oakley, R.; Lee, C. N.; Wong, P. S.; Caleb, M. G.; Salto-Tellez, M.; Bhatia, M.; Chan, E. S. Y.; Taylor, E. A.; Moore, P. K. Contractile and vasorelaxant effects of hydrogen sulfide and its biosynthesis in the human internal mammary artery. J. Pharmacol. Exp. Ther., 2008, 324, 876-882.
28. Stecyk, J. A. W.; Skovgaard, N.; Nilsson, G. E.; Wang, T. Vasoactivity of hydrogen sulfide in normoxic and anoxic turtles (Trachemys scripta). Am. J. Physiol., 2010, 298, R1225-R1239.
29. 2S-induced vasorelaxation and underlying cellular and molecular mechanism. Am. J. Physiol., 2002, 283, 474-H480.
30. Li, L.; Hsu, A.; Moore, P. K. Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation - a tale of three gases! Pharmacol. Ther., 2009, 123, 386-400.
31. Tang, G.; Wu, L.; Wang, R. The Effect of hydroxylamine on KATPchannels in vascular smooth muscle and underlying mechanisms. Mol. Pharmacol., 2005, 67, 1723-1731.
32. Telezhkin, V.; Brazier, S. P.; Cayzac, S.; Müller, C. T.; Riccardi, D.; Kemp, P. J. Hydrogen sulfide inhibits human BKCa channels. In: Arterial Chemoreceptor, Advances in Experimental Medicine and Biology, Gonzalez, C.; Nurse, C.A.; Peers, C. Eds.; Springer-Science, 2009; Vol. 648, pp. 65-72.
33. Kawabata, A.; Ishiki, T.; Nagasawa, K.; Yoshida, S.; Maeda, Y.; Takahashi, T.; Sekiguchi, F.; Wada, T.; Ichida, S.; Nishikawa, H. Hydrogen sulfide as a novel nociceptive messenger. Pain, 2007, 132, 74.81.
34. Garcia-Bereguiain, M. A.; Samhan-Arias, A. K.; Martin-Romero, F. J.; Gutierrez-Merino, C. Hydrogen sulfide raises cytosolic calcium in neurons through activation of L-Type Ca2+ channels. Antioxid. Redox Signal., 2008, 10, 31-41.
35. 2S and HS- donor NaHS inhibits intracellular chloride channels. Gen. Physiol. Biophys., 2009, 28, 190-194.
36. Dalsgaard, T.; Kroigaard, C.; Misfeldt, M.; Bek, T.; Simonsen, U. Openers of small conductance calcium-activated potassium channels selectively enhance NO-mediated bradykinin vasodilatation in porcine retinal arterioles. Br. J. Pharmacol., 2010, 160, 1496-1508.
37. Kiss, L.; Deitch, E. A.; Szabo, C. Hydrogen sulfide decreases adenosine triphosphate levels in aortic rings and leads to vasorelaxation via metabolic inhibition. Life Sci., 2008, 83, 589-594.
38. Lee, S. W.; Cheng, Y.; Moore, P. K.; Bian, J. S. Hydrogen sulphide regulates intracellular pH in vascular smooth muscle cells. Biochem. Biophys. Res. Commun., 2007, 358, 1142-1147.
39. Lim, J. J.; Liu, Y. H.; Khin, E. S.; Bian, J. S. Vasoconstrictive effect of hydrogen sulfide involves downregulation of cAMP in vascular smooth muscle cells. Am. J. Physiol., 2008, 295, C1261-C1270.
40. Geng, B.; Cui, Y.; Zhao, J.; Yu, F.; Zhu, Y.; Xu, G.; Zhang, Z., Tang, C.; Du, J. Hydrogen sulfide downregulates the aortic Larginine/ nitric oxide pathway in rats. Am. J. Physiol., 2007, 293, R1608-R1618.
41. 2S in rat tissues. Can. J. Physiol. Pharm., 2003, 81, 848-853.
42. Whiteman, M.; Li, L.; Kostetski, I.; Chu, S. H.; Siau, J. L.; Bhatia, M.; Moore, P. K. Evidence for the formation of a nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulphide. Biochem. Biophys. Res. Commun., 2006, 343, 303-310.
43. Olson, K. R.; Forgan, L. G.; Dombkowski, R. A.; Forster, M. E. Oxygen dependency of hydrogen sulfide-mediated vasoconstriction in cyclostome aortas. J. Exp. Biol., 2008, 211, 2205-2213.
44. Olson, K. R.; Dombkowski, R. A.; Russell, M. J.; Doellman, M. M.; Head, S. K.; Withfield, N. L.; Madden, J. A. Hydrogen sulfide as an oxygen sensor/transducer in vertebrate hypoxic vasoconstriction and hypoxic vasodilation. J. Exp. Biol., 2006, 209, 4011-4023.
45. Wang, Y. F.; Mainali, P.; Tang, C. S.; Shi, L.; Zhang, C. Y.; Yan, H.; Liu, X. Q.; Du, J. B. Effects of nitric oxide and hydrogen sulfide on the relaxation of pulmonary arteries in rats. Chin. Med. J., 2008, 121, 420-423.
46. von Euler, U. S.; Liljestrand, G. Observations on the pulmonary arterial blood pressure in the cat. Acta. Physiol. Scand., 1946, 12, 301-320.
47. Fishman, A. P. Hypoxia on the pulmonary circulation. How and where it acts. Circ. Res., 1976, 38, 221-231.
48. Brimioulle, S.; Lejeune, P.; Naeije, R. Effects of hypoxic pulmonary vasoconstriction on pulmonary gas exchange. J. Appl. Physiol., 1996, 81, 1535-1543.
49. Faraci, F. M.; Kilgore, D. L.; Fedde, M.R. Attenuated pulmonary pressor response to hypoxia in bar-headed geese. Am. J. Physiol., 1984, 247, R402-R403.
50. Malvin, G. M.; Walker, B. R. Sites and ionic mechanisms of hypoxic vasoconstriction in frog skin. Am. J. Physiol., 2001, 280, R1308-R1314.
51. Smith, M. P.; Russell, M. J.; Winckoa, J. T.; Olson, K. R. Effects of hypoxia on isolated vessels and perfused gills of rainbow trout. Comp. Biochem. Physiol., 2001, 130, 171-181.
52. Skovgaard, N.; Abe, A. S.; Andrade, D. V.; Wang, T. Hypoxic pulmonary vasoconstriction in reptiles: a comparative study on four species with different lung structures and pulmonary blood pressures. Am. J. Physiol., 2005, 289, R1280-1288.
53. Skovgaard, N.; Zibrandtsen, H.; Laursen, B. E.; Simonsen, U.; Wang, T. Hypoxia-induced vasoconstriction in alligator (Alligator mississippiensis) intrapulmonary arteries: a role for endothelin-1? J. Exp. Biol., 2008, 211, 1565-1570.
54. Ward, J. P. Oxygen sensors in context. Biochim. Biophys. Acta, 2008, 1777, 1-14
55. Olson, K. R.; Whitfield, N. L.; Bearden, S. E.; St. Leger, J.; Nilson, E.; Gao, Y.; Madden, J. A. Hypoxic pulmonary vasodilation: a paradigm shift with a hydrogen sulfide mechanism. Am. J. Physiol., 2009, 298, R51-R60.
56. Maclean, K. N.; Kraus, J. P. In: Hydrogen sulfide production and metabolism in mammalian tissues. Signal Transduction and the Gasotransmitters; Wang, R., Ed.; 2004, Humana Press: Totowa, NJ, pp. 275-292.
57. Stipanuk, M. H. Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine. Annu. Rev. Nutr., 2004, 24, 539-577.
58. Banerjee, R.; Zou, C. G. Redox regulation and reaction mechanism of human cystathionine-beta-synthase: a PLP-dependent hemesensor protein. Arch. Biochem. Biophys., 2005, 433, 144-156.
59. Olson, K. R. Hydrogen sulfide and oxygen sensing: implications in cardiorespiratory control. J. Exp. Biol., 2008, 211, 2727-2734.
60. Waypa, G. B.; Schumacker, P. T. Hypoxic pulmonary vasoconstriction: redox events in oxygen sensing. J. Appl. Physiol., 2005, 98, 404-414.
61. Geng, B.; Chang, L.; Pan, C.; Qi, Y.; Zhao, J.; Pang, Y.; Du, J.; Tang, C. Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem. Biophys. Res. Commun., 2004, 318, 756-763.
62. 2S cytotoxicity mechanism involves reactive oxygen species formation and mitochondrial depolarisation. Toxicol., 2004, 203, 69-76.
63. Elsey, D. J.; Fowkes, R. C.; Baxter, G. F. Regulation of cardiovascular cell function by hydrogen sulfide (H(2)S). Cell Biochem. Funct., 2010, 28, 95-106.
64. 2S) protects against regional myocardial ischemiareperfusion injury - evidence for a role of KATP channels. Basic. Res. Cardiol., 2006, 101, 53-60.
65. Osipov, R. M.; Robich, M. P.; Feng, J.; Liu, Y.; Clements, R. T.; Glazer, H. P.; Sodha, N. R.; Szabo, C.; Bianchi, C.; Sellke, F. W. Effect of hydrogen sulfide in a porcine model of myocardial ischemia- reperfusion: comparison of different administration regimens and characterization of the cellular mechanisms of protection. J. Cardiovasc. Pharmacol., 2009, 54, 287-297.
66. 2S generated by heart in rat and its effects on cardiac function. Biochem. Biophys. Res. Commun., 2004, 313, 362-368.
67. Elrod, J. W.; Calvert, J. W.; Morrison, J.; Doeller, J.E.; Kraus, D. W.; Tao, L.; Jiao, X.; Scalia, R.; Kiss, L.; Szabo, C.; Kimura, H.; Chow, C. W.; Lefer, D. J. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc. Natl. Acad. Sci., 2007, 104, 15560-15565.
68. Rossoni, G.; Sparatore, A.; Tazzari, V.; Manfredi, B.; Del, S. P.; Berti, F. The hydrogen sulphide-releasing derivative of diclofenac protects against ischaemia-reperfusion injury in the isolated rabbit heart. Br. J. Pharmacol., 2008, 153, 100-109.
69. Zhang, Z.; Huang, H.; Liu, P.; Tang, C.; Wang, J. Hydrogen sulfide contributes to cardioprotection during ischemia-reperfusion injury by opening K ATP channels. Can. J. Physiol. Pharmacol., 2007, 85, 1248-1253.
70. Bian, J. S.; Yong, Q.C.; Pan, T. T.; Feng, Z. N.; Ali, M. Y.; Zhou, S.; Moore, P. K. Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J. Pharmacol. Exp. Ther., 2006, 316, 670-678.
71. Hu, Y.; Chen, X.; Pan, T. T.; Neo, K. L.; Lee, S.W.; Khin, E. S.; Moore, P.K.; Bian, J. S. Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways. Pflugers Arch., 2008, 455, 607-616.
72. 2S preconditioning-induced PKC activation regulates intracellular calcium handling in rat cardiomyocytes. Am. J. Physiol., 2008, 294, C169-C177.
73. Andreadou, I.; Iliodromitis, E. K.; Farmakis, D.; Kremastinos, D.T. To prevent, protect and save the ischemic heart: antioxidants revisited. Expert Opin. Ther. Targets, 2009, 13, 45-956.
74. 2S/HS- donor. Free Radic. Res., 2009, 43, 581-593.
75. Kimura, Y.; Kimura, H. Hydrogen sulfide protects neurons from oxidative stress. FASEB J., 2004, 18, 1165-1167.
76. Calvert, J. W.; Jha, S.; Gundewar, S.; Elrod, J. W.; Ramachandran, A.; Pattillo, C. B.; Kevil, C. G.; Lefer, D. J. Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ. Res., 2009, 105, 365-374.
77. Elsey, D. J.; Fowkes, R. C.; Baxter, G. F. L-cysteine stimulates hydrogen sulfide synthesis in myocardium associated with attenuation of ischemia-reperfusion injury. J. Cardiovasc. Pharmacol. Ther., 2010, 15, 53-59.
78. Chuah, S.C.; Moore, P. K.; Zhu, Y. Z. S-allylcysteine mediates cardioprotection in an acute myocardial infarction rat model via a hydrogen sulfide-mediated pathway. Am. J. Physiol., 2007, 293, H2693-H2701.
79. Wang, Q.; Liu, H. R.; Mu, Q.; Rose, P.; Zhu, Y. Z. S-propargylcysteine protects both adult rat hearts and neonatal cardiomyocytes from ischemia/hypoxia injury: the contribution of the hydrogen sulfide- mediated pathway. J. Cardiovasc. Pharmacol., 2009, 54, 139-146.
80. Salloum, F. N.; Chau, V.Q.; Hoke, N. N.; Abbate, A.; Varma, A.; Ockaili, R. A.; Toldo, S.; Kukreja, R. C. Phosphodiesterase-5 inhibitor, tadalafil, protects against myocardial ischemia/reperfusion through protein-kinase g-dependent generation of hydrogen sulfide. Circulation, 2009, 120, S31-S36.
81. Yong, Q. C.; Lee, S. W.; Foo, C. S.; Neo, K. L.; Chen, X.; Bian, J. S. Endogenous hydrogen sulphide mediates the cardioprotection induced by ischemic postconditioning. Am. J. Physiol., 2008, 295, H1330-H1340.
82. Ji, Y.; Pang, Q. F.; Xu, G.; Wang, L.; Wang, J. K.; Zeng, Y. M. Exogenous hydrogen sulfide postconditioning protects isolated rat hearts against ischemia-reperfusion injury. Eur. J. Pharmacol., 2008, 587, 1-7.
83. Zhong, G.; Chen, F.; Cheng, Y.; Tang, C.; Du, J. The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase. J. Hypertens., 2003, 21, 1879-1885.
84. Xu, Z.; Prathapasinghe, G.; Wu, N.; Hwang, S. Y.; Siow, Y. L.; Karmin, O. Ischemia-reperfusion reduces cystathionine-beta synthase-mediated hydrogen sulfide generation in the kidney. Am. J. Physiol., 2009, 297, F27-F35.
85. Sen, U.; Basu, P.; Abe, O. A.; Givvimani, S.; Tyagi, N.; Metreveli, N.; Shah, K. S.; Passmore, J. C.; Tyagi, S. C. Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure. Am. J. Physiol., 2009, 297, F410-F419.
86. Yan, H.; Du, J.; Tang, C. The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats. Biochem. Biophys. Res. Commun., 2004, 313, 22-27.
87. Chunyu, Z.; Junbao, D.; Dingfang, B.; Hui, Y.; Xiuying, T.; Chaoshu, T. The regulatory effect of hydrogen sulfide on hypoxic pulmonary hypertension in rats. Biochem. Biophys. Res. Commun., 2003, 302, 810-816.
88. Xiaohui, L.; Junbao, D.; Lin, S.; Jian, L.; Xiuying, T.; Jianguang, Q.; Bing, W.; Hongfang, J.; Chaoshu, T. Down-regulation of endogenous hydrogen sulfide pathway in pulmonary hypertension and pulmonary vascular structural remodeling induced by high pulmonary blood flow in rats. Circ. J., 2005, 69, 1418-1424.
89. Hongfang, J.; Cong, B.; Zhao, B.; Zhang, C.; Liu, X.; Zhou, W.; Shi, Y.; Tang, C.; Junbao, D. Effects of hydrogen sulfide on hypoxic pulmonary vascular structural remodeling. Life Sci., 2006, 78, 1299-1309.
90. Qingyou, Z.; Junbao, D.; Weijin, Z.; Hui, Y.; Chaoshu, T.; Chunyu, Z. Impact of hydrogen sulfide on carbon monoxide/heme oxygenase pathway in the pathogenesis of hypoxic pulmonary hypertension. Biochem. Biophys. Res. Commun., 2004, 317, 30-37.
91. Wei, H. L.; Zhang, C. Y.; Jin, H. F.; Tang, C. S.; Du, J. B. Hydrogen sulfide regulates lung tissue-oxidized glutathione and total antioxidant capacity in hypoxic pulmonary hypertensive rats. Acta Pharmacol. Sin., 2008, 29, 670-679.
92. Li, X.; Du, J.; Jin, H.; Tang, X.; Bu, D.; Tang, C. The regulatory effect of endogenous hydrogen sulfide on pulmonary vascular structure and gasotransmitters in rats with high pulmonary blood flow. Life Sci., 2007, 81, 841-849.
93. Li, X. H.; Du, J.B.; Bu, D. F.; Tang, X. Y.; Tang, C. S. Sodium hydrosulfide alleviated pulmonary vascular structural remodeling induced by high pulmonary blood flow in rats. Acta Pharmacol. Sin., 2006, 27, 971-980.
94. Yanfei, W.; Lin, S.; Junbao, D.; Chaoshu, T. Impact of L-arginine on hydrogen sulfide/cystathionine-gamma-lyase pathway in rats with high blood flow-induced pulmonary hypertension. Biochem. Biophys. Res. Commun., 2006, 345, 851-857.
95. Du, J.; Hui, Y.; Cheung, Y.; Bin, G.; Jiang, H.; Chen, X.; Tang, C. The possible role of hydrogen sulfide as a smooth muscle cell proliferation inhibitor in rat cultured cells. Heart Vessels, 2004, 19, 75-80.
96. Hyvelin, J. M.; Howell, K.; Nichol, A.; Costello, C. M.; Preston, R. J.; McLoughlin, P. Inhibition of Rho-kinase attenuates hypoxiainduced angiogenesis in the pulmonary circulation. Circ. Res., 2005, 97, 185-191.